Application 022433
- Type
- NDA
- Sponsor
- ASTRAZENECA PHARMS
Application Products
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | BRILINTA | TICAGRELOR | TABLET;ORAL | 90MG | Yes | Yes |
| 002 | BRILINTA | TICAGRELOR | TABLET;ORAL | 60MG | Yes | No |
NDC Listings For This Application
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0186-0776 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0776 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0776 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0776 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0776 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0776 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0776 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceutica | NDA | Current |
| 0186-0776 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0776 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0776 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0776 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0777 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0777 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0777 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0777 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0777 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0777 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceutica | NDA | Current |
| 0186-0777 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0777 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0777 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0777 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0777 | BRILINTA | Ticagrelor | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 55154-9618 | BRILINTA | Ticagrelor | Cardinal Health | NDA | Current |
| 55154-9618 | BRILINTA | Ticagrelor | Cardinal Health | NDA | Current |
| 55154-9618 | BRILINTA | Ticagrelor | Cardinal Health | NDA | Current |
| 55154-9618 | BRILINTA | Ticagrelor | Cardinal Health 107, LLC | NDA | Current |
| 55154-9618 | BRILINTA | Ticagrelor | Cardinal Health | NDA | Current |
| 55154-9618 | BRILINTA | Ticagrelor | Cardinal Health 107, LLC | NDA | Current |
| 55154-9618 | BRILINTA | Ticagrelor | Cardinal Health | NDA | Current |
| 55154-9618 | BRILINTA | Ticagrelor | Cardinal Health | NDA | Current |